aNRP2-14

N/A

Report date: 2023/03/12 14:23:38

Base Information

Drug NameaNRP2-14
Drug Alias NamealfaNRP-214aNRP-214alphaNRP-214NRP-214
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNeuropilin 2 inhibitors
TargetsNeuropilin 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtyr Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAtyr Pharma
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A